Replication of genetic associations of chemotherapy-related cardiotoxicity in the adjuvant NSABP B-31 clinical trial

BACKGROUND: The cardiotoxic effects of doxorubicin, trastuzumab, and other anticancer agents are well known, but molecular genetic testing is lacking for the early identification of patients at risk for therapy-related cardiac toxicity. METHODS: Using the Agena Bioscience MassARRAY system, we genoty...

Descripción completa

Detalles Bibliográficos
Autores principales: Advani, Pooja P., Ruddy, Kathryn J., Herrmann, Joerg, Ray, Jordan C., Craver, Emily C., Yothers, Greg, Cecchini, Reena S., Lipchik, Corey, Feng, Huichen, Rastogi, Priya, Mamounas, Eleftherios P., Swain, Sandra M., Geyer, Charles E., Wolmark, Norman, Paik, Soonmyung, Pogue-Geile, Katherine L., Colon-Otero, Gerardo, Perez, Edith A., Norton, Nadine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10248403/
https://www.ncbi.nlm.nih.gov/pubmed/37305569
http://dx.doi.org/10.3389/fonc.2023.1139347

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10248403/
https://www.ncbi.nlm.nih.gov/pubmed/37305569
http://dx.doi.org/10.3389/fonc.2023.1139347

Ejemplares similares